Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
22nd week of 2020 patent applcation highlights part 7
Patent application number
Title
Published
20200163872
BIOLOGICAL SELF-ASSEMBLED NANOCRYSTAL INJECTION HAVING A LYMPHATIC TARGETING FUNCTION AND PREPARATION METHOD
2020-05-28
20200163873
PHARMACEUTICAL COMPOSITION
2020-05-28
20200163874
Oral Sweetener Compositions and Methods
2020-05-28
20200163875
STABLE SOLID FINGOLIMOD DOSAGE FORMS
2020-05-28
20200163876
PHARMACEUTICAL FORMULATIONS OF CYCLOSPORINE ANALOGS
2020-05-28
20200163877
LIPOSOME FORMULATIONS
2020-05-28
20200163878
LIPID NANOPARTICLE MRNA VACCINES
2020-05-28
20200163879
NUCLEIC ACID VECTOR TABLETS
2020-05-28
20200163880
CATIONIC LIPOSOMES
2020-05-28
20200163881
PREPARATION COMPRISING VONOPRAZAN
2020-05-28
20200163882
Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists
2020-05-28
20200163883
NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION
2020-05-28
20200163884
STEALTH NANOPARTICLES
2020-05-28
20200163885
COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL
2020-05-28
20200163886
Controlled-Release Compositions of Melatonin Combined with Sedative and/or Analgesic Ingredients
2020-05-28
20200163887
Process for preparation of an enteric coated granulate comprising dimethyl fumarate
2020-05-28
20200163888
METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT
2020-05-28
20200163889
EXTENDED RELEASE COMPOSITIONS COMPRISING PYRIDOSTIGMINE
2020-05-28
20200163890
TABLET CONTAINING FERRIC CITRATE
2020-05-28
20200163891
PALATABLE ORAL VETERINARY COMPOSITIONS
2020-05-28
20200163892
PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS
2020-05-28
20200163893
ACID RESISTANT BANDING OR SEALING SOLUTION FOR ACID RESISTANT TWO PIECE HARD CAPSULES
2020-05-28
20200163894
ORAL PROLONGED DRUG DELIVERY PLATFORMS
2020-05-28
20200163895
FORMULATIONS OF HOMOTAURINES AND SALTS THEREOF
2020-05-28
20200163896
FLOATABLE PHARMACEUTICAL MICROCAPSULE COMPOSITION
2020-05-28
20200163897
METHODS OF TREATING LIVER DISEASES ASSOCIATED WITH PORTAL TRACT OR PERIPORTAL INFLAMMATION
2020-05-28
20200163898
PEGylated lipid nanoparticle with bioactive lipophilic compound
2020-05-28
20200163899
FUNCTIONALIZED PRUSSIAN BLUE NANOPARTICLES, COMBINATION PRUSSIAN BLUE NANOPARTICLE-BASED NANO-IMMUNOTHERAPY AND APPLICATIONS THEREOF
2020-05-28
20200163900
OCULAR DRUG DELIVERY FORMULATION
2020-05-28
20200163901
THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM
2020-05-28
20200163902
THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF
2020-05-28
20200163903
Buffered Oxygen Therapeutic
2020-05-28
20200163904
ENHANCED PURITY AND METHODS OF USE OF ABLATIVE ALCOHOL
2020-05-28
20200163905
TOPICAL COMPOSITIONS
2020-05-28
20200163906
PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF
2020-05-28
20200163907
USES OF HYDROXYANIGORUFONE
2020-05-28
20200163908
METHODS AND COMPOSITIONS FOR REGULATING GLUCOSE HOMEOSTASIS
2020-05-28
20200163909
TOPICAL SKIN CARE COMPOSITIONS
2020-05-28
20200163910
TOPICAL COMPOSITION FOR PAIN RELIEF
2020-05-28
20200163911
METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
2020-05-28
20200163912
METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
2020-05-28
20200163913
CA-4 Antitumour Drug, Synthesis Method and Use Thereof
2020-05-28
20200163914
AGENT FOR THE PROPHYLACTIC AND/OR SUPPORTIVE THERAPEUTIC TREATMENT OF PARKINSON'S DISEASE
2020-05-28
20200163915
TREATMENT OF DISEASES BY CONCURRENTLY ELICITING REMYELINATION EFFECTS AND IMMUNOMODULATORY EFFECTS USING SELECTIVE RXR AGONISTS
2020-05-28
20200163916
PROBENECID FOR USE IN TREATING EPILEPTIC DISEASES, DISORDERS OR CONDITIONS
2020-05-28
20200163917
PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPERACTIVE BLADDER
2020-05-28
20200163918
POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS
2020-05-28
20200163919
AMINO ACID COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY
2020-05-28
20200163920
METHOD FOR REDUCING LUNG INFLAMMATION
2020-05-28
20200163921
METHODS OF TREATING CHRONIC DRY EYE DISEASE USING C16:1n7-PALMITOLEATE AND DERIVATIVES THEREOF
2020-05-28
20200163922
COMPOSITIONS AND METHODS FOR RESOLUTION OF INFLAMMATION
2020-05-28
20200163923
MARESINS FOR USE IN THE TREATMENT OF CNS INJURIES
2020-05-28
20200163924
COMPOSITIONS AND METHODS FOR REACTIVATING LATENT VIRAL INFECTIONS
2020-05-28
20200163925
METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT AT RISK FOR CARDIOVASCULAR DISEASE
2020-05-28
20200163926
BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES
2020-05-28
20200163927
METHODS AND COMPOSITIONS FOR TREATING EXCESSIVE SLEEPINESS
2020-05-28
20200163928
Taxane Particles and Their Use
2020-05-28
20200163929
PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS
2020-05-28
20200163930
COMPOUNDS FOR TREATING CANCER
2020-05-28
20200163931
ORAL COMPOSITION OF EXTRACTED CANNABINOIDS AND METHODS OF USE THEREOF
2020-05-28
20200163932
CANNABINOID COMPOSITIONS AND USES
2020-05-28
20200163933
INHIBITORS OF MICROBIALLY INDUCED AMYLOID
2020-05-28
20200163934
Solid Pharmaceutical Preparation Containing Lipoic Acid And Use Thereof
2020-05-28
20200163935
SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
2020-05-28
20200163936
Oxo-M and 4-PPBP induction of tenogenic differentiation of perivascular tendon stem cells
2020-05-28
20200163937
PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
2020-05-28
20200163938
PHARMACEUTICAL COMPOSITION COMPRISING IRON CHELATOR EXHIBITING ANTITUMOR ACTIVITY, ANTIBACTERIAL ACTIVITY AND/OR ANTIVIRUS ACTIVITY, AND HAVING REDUCED SIDE EFFECTS
2020-05-28
20200163939
COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE AND ANALOGS AND DERIVATIVES THEREOF
2020-05-28
20200163940
COMPOSITIONS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE AND ANALOGS AND DERIVATIVES THEREOF
2020-05-28
20200163941
METHOD FOR TREATING NEURODEGENERATIVE DISEASES
2020-05-28
20200163942
COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING A VASCULAR DISRUPTING AGENT AND IMMUNE CHECKPOINT INHIBITOR
2020-05-28
20200163943
METHODS FOR TREATING DRAVET SYNDROME
2020-05-28
20200163944
TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF LIFE
2020-05-28
20200163945
USE OF EZH2 INHIBITORS FOR TREATING CANCER
2020-05-28
20200163946
THERAPEUTIC COMPOUNDS
2020-05-28
20200163947
METHODS OF TREATMENT USING NIMODIPINE PARENTERAL FORMULATIONS
2020-05-28
20200163948
ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
2020-05-28
20200163949
SELECTIVE NR2B ANTAGONISTS
2020-05-28
20200163950
PIPERIDINE-DIONE DERIVATIVES FOR USE AS CONTRACEPTIVES
2020-05-28
20200163951
COMPOSITION AND METHODS FOR THE TREATMENT OF MYOPIA
2020-05-28
20200163952
COMPOSITIONS AND METHODS FOR TREATING NERVE AGENT EXPOSURE
2020-05-28
20200163953
Compounds for Inhibition of Alpha 4 Beta 7 Integrin
2020-05-28
20200163954
Dosing of Cabozantinib Formulations
2020-05-28
20200163955
STERILE COMPOSITIONS OF INDACATEROL SUITABLE FOR NEBULIZATION
2020-05-28
20200163956
DIRECT BRAIN ADMINISTRATION OF CHEMOTHERAPEUTICS TO THE CSF FOR PATIENTS WITH PRIMARY AND SECONDARY BRAIN TUMORS
2020-05-28
20200163957
METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION
2020-05-28
20200163958
USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
2020-05-28
20200163959
1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT
2020-05-28
20200163960
INJECTABLE FORMULATION
2020-05-28
20200163961
Bicyclic Compounds and Methods for Their Use in Treating Autistic Disorder and Autism
2020-05-28
20200163962
PHARMACEUTICAL COMPOSITION OF NILOTINIB
2020-05-28
20200163963
CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS
2020-05-28
20200163964
IMIDAZOLIDINEDIONE DERIVATIVES
2020-05-28
20200163965
METHODS OF TREATING HEAVY MENSTRUAL BLEEDING
2020-05-28
20200163966
METHODS AND COMPOSITIONS FOR TREATING MELANOMA
2020-05-28
20200163967
USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS CAUSED BY TREATMENT WITH A MEK INHIBITOR
2020-05-28
20200163968
USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
2020-05-28
20200163969
Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
2020-05-28
20200163970
HETEROCYCLIC COMPOUND
2020-05-28
20200163971
IMEGLIMIN FOR PREVENTING AND/OR TREATING HEPATOCELLULAR CARCINOMA
2020-05-28